Get the content you want anytime you want.
REGISTER NOW | SIGN IN
ARTICLE

Top 5 Contagion® News Articles for the Week of July 30, 2017

AUG 05, 2017 | CONTAGION® EDITORIAL STAFF

#1: 5 New HIV Drugs in the Pipeline

More than 36 million people worldwide are living with HIV, according to the World Health Organization (WHO). Therefore, inexpensive, effective, and long-lasting medications are essential if the scientific community wants to successfully treat them.

Problems with adherence that plagued many individuals could be alleviated with the addition of new longer-acting HIV medications. These long-acting medications may also reduce costly laboratory tests to monitor their efficacy, and bring down drug costs—a major factor in middle- and low-income countries where HIV is most prevalent.
 
“With several highly potent agents in the pipeline and a healthy proliferation of many promising technologies for long-acting delivery, the prospects for very long-acting ARVs [anti-retrovirals] for treatment and prevention have never been brighter,” said Matthew Barnhart MD, MPH,  medical officer for the US Agency for International Development (USAID) and associate editor of Global Health: Science and Practice in a recent editorial.

Dr. Barnhart outlined and described 5 types of drug developments that put HIV treatment on the threshold of a breakthrough.

Learn about the 5 HIV drugs in the pipeline, here.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
Big advances in treatment can